Patient Centricity in Skin Treatments: Global Meeting of Experts in Dermatology

Helen Boreham
{"title":"Patient Centricity in Skin Treatments: Global Meeting of Experts in Dermatology","authors":"Helen Boreham","doi":"10.33590/emjdermatol/10302314","DOIUrl":null,"url":null,"abstract":"During this symposium, global experts in dermatology gave a series of lectures focused on skin treatments and their benefits for patients. Giuseppe Micali, University of Catania, Italy, provided a non-invasive skin imaging perspective on the skin journey over time, exploring the changes in the functional integrity of ageing skin, and associated dermatological needs. Positive findings from a clinical study evaluating U-Life™ 10 (Relife Menarini Group, Florence, Italy), a 10% urea cream, in the treatment of senile xerosis were also presented. The second lecture, presented by Giovanni Pellacani, Sapienza University, Rome, Italy, reviewed the pathogenesis of eczema, and the key role of oxidation in skin barrier impairment and inflammation. A recent study evaluating the clinical performance of Relizema™ cream (Menarini Group), a steroid-free medical device, for topical use demonstrated that it effectively reduced the severity of symptoms in adults with atopic and contact dermatitis, and was well-tolerated. The final presentation by Micali focused on salicylic acid-based products containing active ingredients that target multiple pathogenetic factors of acne. Findings from a multicentre, prospective, observational study of this new salicylic acid-based acne daily regimen showed promising improvements in patients with mild acne.","PeriodicalId":90162,"journal":{"name":"European medical Journal. Urology","volume":"44 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European medical Journal. Urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33590/emjdermatol/10302314","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

During this symposium, global experts in dermatology gave a series of lectures focused on skin treatments and their benefits for patients. Giuseppe Micali, University of Catania, Italy, provided a non-invasive skin imaging perspective on the skin journey over time, exploring the changes in the functional integrity of ageing skin, and associated dermatological needs. Positive findings from a clinical study evaluating U-Life™ 10 (Relife Menarini Group, Florence, Italy), a 10% urea cream, in the treatment of senile xerosis were also presented. The second lecture, presented by Giovanni Pellacani, Sapienza University, Rome, Italy, reviewed the pathogenesis of eczema, and the key role of oxidation in skin barrier impairment and inflammation. A recent study evaluating the clinical performance of Relizema™ cream (Menarini Group), a steroid-free medical device, for topical use demonstrated that it effectively reduced the severity of symptoms in adults with atopic and contact dermatitis, and was well-tolerated. The final presentation by Micali focused on salicylic acid-based products containing active ingredients that target multiple pathogenetic factors of acne. Findings from a multicentre, prospective, observational study of this new salicylic acid-based acne daily regimen showed promising improvements in patients with mild acne.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
以患者为中心的皮肤治疗:全球皮肤病学专家会议
在本次研讨会上,全球皮肤学专家就皮肤治疗及其对患者的益处进行了一系列讲座。意大利卡塔尼亚大学的Giuseppe Micali提供了一种非侵入性皮肤成像的视角,研究了皮肤老化过程中功能完整性的变化,以及相关的皮肤病学需求。一项评估10%尿素乳膏U-Life™10 (Relife Menarini Group, Florence, Italy)治疗老年性干枯症的临床研究也给出了阳性结果。第二场讲座由意大利罗马Sapienza大学的Giovanni Pellacani主讲,他回顾了湿疹的发病机制,以及氧化在皮肤屏障损伤和炎症中的关键作用。最近的一项研究评估了Relizema™霜(美纳里尼集团)的临床性能,这是一种不含类固醇的医疗器械,用于局部使用,表明它有效地减轻了成人特应性和接触性皮炎症状的严重程度,并且耐受性良好。Micali的最后一次演讲集中在含有针对痤疮多种致病因素的活性成分的水杨酸产品上。一项多中心、前瞻性、观察性研究发现,这种新的基于水杨酸的痤疮日常治疗方案对轻度痤疮患者有很大的改善。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
17 weeks
期刊最新文献
The Unmet Need for Patients with Vitiligo is High Diagnostic Evaluation of Hair Loss: A Narrative Review Patient Centricity in Skin Treatments: Global Meeting of Experts in Dermatology EADV 2023 Interview: Shyam Verma Shaping the Future of Coronary Interventions by Highlighting Coronary Anatomy and Reducing Contrast Volume
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1